You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

COVID-19 Resource Center

Healthcare professionals can find help and guidance on how to benefit from our offerings to treat your patients, as well as other practical information and advice.

Read more

Nyheter

Extraordinary General Meeting in Getinge authorized the Board to resolve on a rights issue of maximum SEK 2,000 million

Not for release, publication or distribution, directly or indirectly, in the United States, Canada, Australia, Hong Kong or Japan Press release November 14, 2008

Extraordinary General Meeting in Getinge authorized the Board to resolve on a rights issue of maximum SEK 2,000 million

At today’s Extraordinary General Meeting (”EGM”) of Getinge AB (“Getinge”), the Board of Directors was authorized to resolve – on one or several occasions up until the next Annual General Meeting – to increase Getinge’s share capital by way of issuing new shares with preferential right for Getinge’s shareholders. The Board is authorized to resolve to issue new shares to such an extent that the total proceeds of issue amount to a maximum of SEK 2,000 million, provided that new shares can be issued without amendments to the Articles of Association. The Board is entitled to establish all other terms of issue.

As previously announced, the Board intends to set the following principal terms for the rights issue:

• Subscription ratio: one (1) new Class A share and Class B share for each nine (9) existing Class A shares and Class B shares held, respectively

• Subscription price: SEK 83,50 per share

The rights issue, if fully subscribed, will raise proceeds to Getinge amounting to approximately SEK 1,990 million before deduction for costs related to the rights issue. A formal resolution on the rights issue, including the full terms, will be adopted by the Board once the authorization has been registered with the Swedish Companies Registration Office (Bolagsverket).

It is expected that the prospectus in respect of the rights issue can be made public at the end of November with the subscription period to be in December.

Getinge’s main shareholder, Carl Bennet AB, representing 18.0% of the capital and 48.8% of the votes in Getinge, has declared that the company will undertake to subscribe for its position of the planned rights issue as well as all shares not subscribed and paid for by other shareholders.

Financial and legal advisor
SEB Enskilda is financial advisor to Getinge. Mannheimer Swartling is legal advisor.

Getinge, November 14, 2008
Getinge AB (publ)
www.getingegroup.com

For further information:
Johan Malmquist, CEO
Ulf Grunander, CFO
+46 (0)35 15 55 00

The information is such that Getinge AB must disclose in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication on November 14, 2008, at noon CET.

Files

Del: